Catalyst Wire Dossier Catalyst Wire Dossier

Suzetrigine (SUZ)

Suzetrigine · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Suzetrigine (SUZ), covering 2026-01-29 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]

See pricing